Intrapericardial botulinum toxin treatment for bradycardia
View Patent ↗Methods for treating cardiac muscle disorders, such as cardiac arrhythmias, by administration of a neurotoxin to cardiac muscle are disclosed. Bradycardia can be alleviated for several months by a single intrapericardial or intracardiac injection or infusion of a botulinum toxin. Tachycardia can be alleviated by preganglionic sympathetic nervous system administration of a botulinum toxin.
1. A method for treating bradycardia, the method comprising the step of intrapericardial injection of a botulinum toxin to the sinoatrial node or to the atrioventricular node of a heart of a patient with bradycardia, thereby treating bradycardia.
2. The method of claim 1 , wherein the botulinum toxin is botulinum toxin type A and the amount of botulinum toxin type A locally administered to the heart is between about 0.01 U/kg and about 35 U/kg.
3. The method of claim 1 wherein the botulinum toxin is botulinum toxin type A and the amount of botulinum toxin type A locally administered to the heart is between about 0.1 U/kg and about 30 U/kg.
4. The method of claim 1 , wherein the botulinum toxin is botulinum toxin A and the amount of botulinum toxin A locally administered to the heart is between about 1 U/kg and about 25 U/kg.
5. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxins types A, B, C, D, E, F and G.
6. A method for treating bradycardia, the method comprising the step of intrapericardial injection of botulinum toxin type A to the sinoatrial node or to the atrioventricular node of a heart of a patient with bradycardia, thereby treating bradycardia.